Guangzhou Baiyunshan Pharmaceutical Stock Annual Yield
GZPHFDelisted Stock | USD 2.88 0.00 0.00% |
Guangzhou Baiyunshan Pharmaceutical fundamentals help investors to digest information that contributes to Guangzhou Baiyunshan's financial success or failures. It also enables traders to predict the movement of Guangzhou Pink Sheet. The fundamental analysis module provides a way to measure Guangzhou Baiyunshan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangzhou Baiyunshan pink sheet.
Guangzhou |
Guangzhou Baiyunshan Pharmaceutical Company Annual Yield Analysis
Guangzhou Baiyunshan's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Guangzhou Baiyunshan Annual Yield | 0.04 % |
Most of Guangzhou Baiyunshan's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangzhou Baiyunshan Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Guangzhou Baiyunshan Pharmaceutical has an Annual Yield of 0.0357%. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The annual yield for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Guangzhou Fundamentals
Return On Equity | 0.13 | |||
Return On Asset | 0.0356 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 5.65 B | |||
Shares Outstanding | 219.9 M | |||
Shares Owned By Institutions | 33.99 % | |||
Price To Earning | 6.77 X | |||
Price To Book | 0.78 X | |||
Price To Sales | 0.11 X | |||
Revenue | 69.01 B | |||
Gross Profit | 13.19 B | |||
EBITDA | 5.46 B | |||
Net Income | 3.72 B | |||
Cash And Equivalents | 21.72 B | |||
Cash Per Share | 13.36 X | |||
Total Debt | 752.81 M | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 1.65 X | |||
Book Value Per Share | 19.33 X | |||
Cash Flow From Operations | 5.67 B | |||
Earnings Per Share | 0.35 X | |||
Number Of Employees | 25.44 K | |||
Beta | 0.7 | |||
Market Capitalization | 6.95 B | |||
Total Asset | 66.12 B | |||
Z Score | 6.4 | |||
Annual Yield | 0.04 % | |||
Net Asset | 66.12 B | |||
Last Dividend Paid | 0.69 |
About Guangzhou Baiyunshan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangzhou Baiyunshan Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangzhou Baiyunshan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangzhou Baiyunshan Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Guangzhou Pink Sheet
If you are still planning to invest in Guangzhou Baiyunshan check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guangzhou Baiyunshan's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |